ArticleCPT: pharmacometrics & systems pharmacology2026
PMX-CovEval: A Framework Including a Simulated Pharmacokinetic Database for Covariate Model Building Methods Benchmarking.
Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of new methods for covariate model building (CMB) in population pharmacokinetics (popPK) highlights the need for a standardized evaluation framework for method benchmarking. This data paper introduces PMX-CovEval, a framework including a collection of datasets based on 127 distinct scenarios. These scenarios aim to reflect the diversity of models, available clinical studies, and covariates encountered in real-world applications, while remaining limited enough in number to encourage their practical use. To support the evaluation of standard CMB techniques available on PsN and Monolix, model files for NONMEM and Monolix are provided alongside the datasets. Additionally, empirical Bayes estimates (EBEs) from the true base models are included to facilitate the testing of EBE-based regression approaches. By offering pharmacokinetic (PK) datasets, model files, and EBEs in a unified resource, PMX-CovEval provides a standardized, reproducible framework for evaluation and systematic comparison of CMB strategies in popPK. Initial benchmarking results are also provided.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.